Anti-I22R2/ IL22RA2/ CRF2-10 monoclonal antibody

Anti-I22R2/ IL22RA2/ CRF2-10 antibody for FACS & in-vivo assay

Target products collectionGo to IL22RA2/IL22RA2 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-MP0626-Ab-1/ GM-Tg-hg-MP0626-Ab-2Anti-Human IL22RA2 monoclonal antibodyHuman
GM-Tg-rg-MP0626-Ab-1/ GM-Tg-rg-MP0626-Ab-2Anti-Rat IL22RA2 monoclonal antibodyRat
GM-Tg-mg-MP0626-Ab-1/ GM-Tg-mg-MP0626-Ab-2Anti-Mouse IL22RA2 monoclonal antibodyMouse
GM-Tg-cynog-MP0626-Ab-1/ GM-Tg-cynog-MP0626-Ab-2Anti-Cynomolgus/ Rhesus macaque IL22RA2 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-MP0626-Ab-1/ GM-Tg-felg-MP0626-Ab-2Anti-Feline IL22RA2 monoclonal antibodyFeline
GM-Tg-cang-MP0626-Ab-1/ GM-Tg-cang-MP0626-Ab-2Anti-Canine IL22RA2 monoclonal antibodyCanine
GM-Tg-bovg-MP0626-Ab-1/ GM-Tg-bovg-MP0626-Ab-2Anti-Bovine IL22RA2 monoclonal antibodyBovine
GM-Tg-equg-MP0626-Ab-1/ GM-Tg-equg-MP0626-Ab-2Anti-Equine IL22RA2 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-MP0626-Ab-1/ GM-Tg-hg-MP0626-Ab-2; GM-Tg-rg-MP0626-Ab-1/ GM-Tg-rg-MP0626-Ab-2;
GM-Tg-mg-MP0626-Ab-1/ GM-Tg-mg-MP0626-Ab-2; GM-Tg-cynog-MP0626-Ab-1/ GM-Tg-cynog-MP0626-Ab-2;
GM-Tg-felg-MP0626-Ab-1/ GM-Tg-felg-MP0626-Ab-2; GM-Tg-cang-MP0626-Ab-1/ GM-Tg-cang-MP0626-Ab-2;
GM-Tg-bovg-MP0626-Ab-1/ GM-Tg-bovg-MP0626-Ab-2; GM-Tg-equg-MP0626-Ab-1/ GM-Tg-equg-MP0626-Ab-2
Products NameAnti-IL22RA2 monoclonal antibody
Formatmab
Target NameIL22RA2
Protein Sub-locationTransmembrane Protein
Category of antibodyFACS/Biofunctional Antibody, Cytokine antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by using flow cytometry with antigen overexpressed cell line. The biofunction of antibodies are validated in cell-based assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-IL22RA2 benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, FACS,ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation Lyophilized from sterile PBS, PH 7.4
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenProducts DevelopingMulti-species I22R2/ IL22RA2/ CRF2-10 VLP (virus-like particle) (Products Developing)
    CytokineGM-Tg-g-MP0626-Ag-1interleukin 22 receptor, alpha 2 (IL22RA2) protein


    Target information

    Target IDGM-MP0626
    Target NameIL22RA2
    Gene ID116379,237310,444986,711059,100856046,101083429,533061,100073194
    Gene Symbol and SynonymsCRF2-10,CRF2-S1,CRF2X,IL-22BP,IL-22R-alpha-2,IL-22RA2,IL22RA2,ZCYTOR16
    Uniprot AccessionQ969J5,Q7TNI4
    Uniprot Entry NameI22R2_HUMAN,I22R2_RAT
    Protein Sub-locationTransmembrane Protein
    CategoryCytokine Target
    DiseaseN/A
    Gene EnsemblENSG00000164485
    Target ClassificationN/A

    The target: IL22RA2, gene name: IL22RA2, also named as CRF2-10, CRF2-S1, CRF2X, IL-22BP, IL-22R-alpha-2, IL-22RA2, ZCYTOR16. This gene encodes a member of the class II cytokine receptor family. The encoded soluble protein specifically binds to and inhibits interleukin 22 activity by blocking the interaction of interleukin 22 with its cell surface receptor. The encoded protein may be important in the regulation of inflammatory response, and has been implicated in the regulation of tumorigenesis in the colon. Alternative splicing results in multiple transcript variants encoding distinct isoforms. [provided by RefSeq, Jul 2013].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.